theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Gynecologic Oncology

ASCO 2025   

Questions discussed in this category


What are your top takeaways in Gyn Cancers from ASCO 2025?
2 Answers available
24657


Papers discussed in this category


Annals of oncology : official journal of the European Society for Medical Oncology, 2025 May 30
Dostarlimab and niraparib in primary advanced ovarian cancer.

Lancet (London, England), 2025 Jun 02
Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial.

Annals of oncology : official journal of the European Society for Medical Oncology, 2025 Jun 02
Ultrasensitive detection and tracking of circulating tumor DNA to predict relapse and survival in patients with locally advanced cervical cancer: phase III CALLA trial analyses.

Related Topics in Gynecologic Oncology

  • Lung Cancer
  • Breast Cancer
  • Head and Neck Cancers
  • Hematologic Malignancies
  • Radiation Oncology
  • Palliation
  • Neuro-Oncology
  • Gastrointestinal Cancers
  • Genitourinary Cancers
  • Melanoma/Skin Cancer

Copyright © 2025 theMednet
All Rights Reserved.